Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
PR01 - Press Conference
- 16:00 - 17:30
- 9/07/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track:
-
+
PR01.03 - 20th WCLC Highlights
16:20 - 16:32
- Abstract
No abstract available for this presentation
-
+
S02 - Symposium Honoring Dr. Gazdar's Legacy (Sign Up Required)
- 17:30 - 19:00
- 9/07/2019
- Location: Tokyo (1982)
- Type: Symposium
- Track: Pathology
- Moderators:Fred R. Hirsch, Tetsuya Mitsudomi, Ignacio Wistuba
-
+
S02.03 - The Impact of Cell Line Development in Lung Cancer Research
17:45 - 18:00 | Presenter: Paul A Bunn, Jr
- Abstract
Loading...
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.03 - Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Luis Paz-Ares | Author(s): David R Spigel, Yuanbin Chen, Maria Jove, Oscar Juan, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Tiffany Wang, Natalya Nazarenko, Santiago Ponce, Paul A Bunn, Jr
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-87 - Acquired Resistance Mechanisms and Clinical Outcomes for Patients with Epidermal Growth Factor Receptor (EGFR) Positive Non-Small Cell Lung Cancer (NSCLC) Treated with Osimertinib
09:45 - 09:45 | Presenter: Tejas Patil | Author(s): Anastasios Dimou, Jose Pacheco, Derek E Smith, Dara Aisner, Dan Merrick, Chad Rusthoven, Brian Kavanaugh, Ronni Miller, Erin Schenk, D. Ross Camidge, Paul A Bunn, Jr, Robert C. Doebele
- Abstract
Loading...
-
+
ES18 - Acquired Resistance to TKIs: The Rebiopsy Case and the Future Options
- 11:00 - 12:30
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Targeted Therapy
- Moderators:Teresa Moran, Matteo Giaj Levra
-
+
ES18.03 - New Strategies to Overcome Resistance in EGFR Mutated NSCLC
11:40 - 12:00 | Presenter: Paul A Bunn, Jr
- Abstract
Loading...
-
+
P2.03 - Biology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
-
+
P2.03-06 - Detection of ctDNA and Correlation with Tumor Mutation Testing in Early Stage NSCLC
10:15 - 10:15 | Presenter: Anastasios Dimou | Author(s): Tejas Patil, Alyssa Jeffers, Amy Guimaraes-Young, Kurtis D. Davies, Tracy Nance, Yupeng He, Ariel Jaimovich, Victoria M Raymond, AmirAli Talasaz, Erin Schenk, Jose Pacheco, Dara Aisner, Daniel Merrick, Christopher Scott, JOHN D Mitchell, Michael Weyant, Robert A. Meguid, W. Thomas Purcell, Paul A Bunn, Jr, D. Ross Camidge, Terry L Ng, Caroline McCoach, Robert C. Doebele
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-88 - Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
10:15 - 10:15 | Presenter: Jay M Lee | Author(s): Jamie E. Chaft, Alan Nicholas, G Alec Patterson, Saiama Waqar, ERIC M Toloza, Eric B Haura, DAN J Raz, Karen L Reckamp, ROBERT E Merritt, Dwight Hall Owen, DAVID J Finley, CIARAN J McNamee, Justin D Blasberg, Edward Garon, JOHN D Mitchell, Robert C. Doebele, FRANK A Baciewicz, Misako Nagasaka, Harvey I Pass, Ann Johnson, See-Chun Phan, Katja Schulze, Paul A Bunn, Jr, Bruce E Johnson, Mark G Kris, David J Kwiatkowski, Ignacio Wistuba, David P Carbone, Valerie W. Rusch
- Abstract
Loading...
-
+
OA13 - Ideal Approach to Lung Resection and Novel Perioperative Therapy
- 11:30 - 13:00
- 9/10/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Tomasz Grodzki, Kenji Suzuki
-
+
OA13.07 - Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3
12:30 - 12:40 | Presenter: Filiz Oezkan | Author(s): Kai He, Dwight Hall Owen, Maciej Pietrzak, Ju Hwan Cho, Rhonda Kitzler, Rebecca Pearson, Valerie W. Rusch, Jamie E. Chaft, Robert Suh, Justin D Blasberg, Karen L Reckamp, Dan J Raz, Peter J Kneuertz, Lauren Fiorillo, Edward Garon, Alan Nicholas, Ann Johnson, Katja Schulze, Jessica Grindheim, Romain Banchereau, See-Chun Phan, Paul A Bunn, Jr, David J Kwiatkowski, Bruce E Johnson, Mark G Kris, Ignacio Wistuba, Jay M Lee, Gerard Lozanski, David P Carbone
- Abstract
Loading...